Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2

Mounjaro

Image
Ozempic
HealthTechScience
Weight-loss drugs show possible positive effects in HIV, cancer and other diseases
3 July 2026 - 06:30
Image
Ozempic
Health
Hundreds of thousands of Dutch use Ozempic to lose weight; Third without prescription
24 June 2026 - 15:20
Image
Ozempic
HealthBusiness
Dutch spending on diabetes meds jumped 76% in 4 years, largely due to "Ozempic effect"
2 December 2025 - 14:30
Image
Packaging box of Wegovy (semaglutide), an injectable prescription medication, weight-loss drug by pharmaceutical Novo Nordisk, in a pharmacy
Health
Dutch healthcare institute could add 2 more obesity medicines to basic health insurance
6 November 2025 - 08:58
Image
Ozempic
Health
Pricey Ozempic for weight loss is increasing the Dutch health gap, experts fear
28 January 2025 - 08:07
Image
Mounjaro, an injectable medicine used to treat Type 2 diabetes and obesity
Health
Ozempic competitor Mounjaro to soon hit Dutch market
8 October 2024 - 10:20

Latest stories

  • What international businesses should know about sea freight
  • Dutch gardens average 10 butterflies each as long-term decline persists
  • Adults with migrant backgrounds wait months for swimming lessons as drownings rise
  • No more bags on seats on Dutch trains? NS wants bags on laps as the 'new normal'
  • Heat waves put Dutch psychiatric patients at greater risk, doctors warn

Top stories

  • Court: Dutch Cabinet was allowed to ban U.S. takeover of DigiD firm Solvinity
  • OLVG hospital in Amsterdam starts trial with late abortions
  • One killed in stabbing on Roermond street; Suspect arrested
  • Netherlands to start military exercises with Ukraine, help design new air defense system
  • Ter Apel asylum center area declared safety risk zone after recent stabbings, fights

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content